Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers

NCT05509153 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.

NCT NCT05509153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05509153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers
Lead sponsor
Western Sydney Local Health District
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2024
Completion date
May 1, 2027
Enrollment
160 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease